Study guide
14.3 Liver, Biliary Tree & Pancreas
NBME Comprehensive Basic Science Examination CBSE
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Navigation
1.1 Current Exam Facts & Administration 1.2 Content Blueprint & Physician Tasks 1.3 Scoring, Score Reports & Step 1 Readiness
2 Human Development
2.1 Embryology & Congenital Development Patterns 2.2 Normal Age-Related Findings & Well-Patient Care
3 Blood & Hematologic Disease
3.1 Hematopoiesis, RBC Disorders & Anemias 3.2 Hemostasis, Thrombosis & Coagulopathies 3.3 WBC Disorders, Leukemia & Lymphoma Mechanisms
4 Immune System
4.1 Innate & Adaptive Immunity Mechanisms 4.2 Hypersensitivity, Autoimmunity & Immunodeficiency 4.3 Transplant Immunology & Immune Pharmacology
5 Nervous System Anatomy & Disease
5.1 Neuroanatomy Localization & Pathways 5.2 Stroke, Infection, Demyelination & Trauma 5.3 Seizures, Movement Disorders & Neurodegeneration 5.4 Special Senses: Eye & Ear Mechanisms
6 Behavioral Health
6.1 Psychiatric Disorders & Diagnostic Patterns 6.2 Psychopharmacology Mechanisms 6.3 Neurotransmitters, Learning & Behavioral Science
7 Musculoskeletal System
7.1 Bone Physiology, Fracture Healing & Bone Pathology 7.2 Joint Disease, Rheumatology & Connective Tissue 7.3 Muscle, NMJ & Peripheral Nerve Disorders
8 Skin & Soft Tissue
8.1 Dermatopathology High-Yield Lesions 8.2 Inflammation, Wound Healing & Soft-Tissue Infection
9 Cardiovascular Pathophysiology
9.1 Cardiac Cycle, Hemodynamics & Murmurs 9.2 Ischemic Heart Disease & Cardiomyopathy 9.3 Congenital & Valvular Heart Disease 9.4 Vascular Pathology & Hypertension
10 Cardiovascular Pharmacology
10.1 Antihypertensives, Heart Failure & Antiarrhythmics 10.2 Antiplatelets, Anticoagulants & Lipid Drugs
11 Respiratory System
11.1 Pulmonary Mechanics & Gas Exchange 11.2 Obstructive, Restrictive & Vascular Lung Disease 11.3 Pulmonary Infections, Neoplasms & Respiratory Pharmacology
12 Renal Physiology & Electrolytes
12.1 Nephron Transport & Renal Physiology 12.2 Electrolyte Disorders 12.3 Acid-Base Physiology & Compensation
13 Renal Pathology
13.1 Glomerular Disease Mechanisms 13.2 Tubulointerstitial, Vascular & Stone Disease
14 Gastrointestinal System
14.1 GI Physiology, Motility & Digestion 14.2 Esophagus, Stomach & Intestinal Pathology 14.3 Liver, Biliary Tree & Pancreas 14.4 GI Microbiology, Nutrition & Malabsorption
15 Endocrine System
15.1 Hormone Signaling & Hypothalamic-Pituitary Axes 15.2 Thyroid & Parathyroid Disease 15.3 Adrenal Disorders & Steroid Pharmacology 15.4 Diabetes, Glucose Homeostasis & Metabolic Syndrome
16 Reproductive System
16.1 Male & Female Reproductive Physiology 16.2 Pregnancy, Placenta & Developmental Toxicology 16.3 Reproductive Pathology & Hormone-Related Neoplasia
17 Multisystem Processes & Disorders
17.1 Cell Injury, Inflammation & Repair 17.2 Neoplasia Principles & Tumor Biology 17.3 Infection, Sepsis & Multisystem Microbial Disease 17.4 Genetics, Inborn Errors & Environmental Toxicology
18 Biostatistics & Epidemiology
18.1 Study Design, Bias & Causation 18.2 Diagnostic Test Metrics & Screening 18.3 Epidemiology Measures & Population Health
19 Social Sciences & Communication
19.1 Ethics Principles & Decision-Making Capacity 19.2 Communication Skills & Difficult Conversations 19.3 Professionalism, Systems & Practice-Based Learning
20 Integrated Disciplines Capstone
20.1 High-Yield Microbiology Anchors Across Systems 20.2 High-Yield Biochemistry & Molecular Mechanisms 20.3 Integrated Pharmacology Strategy & Exam-Day Execution
14.3 Liver, Biliary Tree & Pancreas
Key Takeaways Explain This Topic AI
Unconjugated hyperbilirubinemia reflects hemolysis or impaired conjugation (Gilbert, Crigler–Najjar); conjugated hyperbilirubinemia reflects hepatocellular excretion defects or obstruction (Dubin–Johnson, Rotor, cholestasis, stones, stricture).
Hepatitis serologies: HAV IgM = acute; HBV—HBsAg marks infection, anti-HBc IgM acute, anti-HBs immunity; HBeAg/HBV DNA track replication; HCV Ab + RNA confirm; HEV fecal–oral, severe in pregnancy.
Alcoholic hepatitis classically AST:ALT ≥2:1; NAFLD/NASH is metabolic; cirrhosis yields portal hypertension sequelae (varices, ascites, splenomegaly, encephalopathy, hepatorenal patterns).
Hemochromatosis (Fe, HFE), Wilson (Cu, ATP7B, low ceruloplasmin), α1-antitrypsin (PAS+ globules, PiZZ) are high-yield metabolic liver diseases; PBC (anti-mitochondrial, middle-aged women) vs PSC (p-ANCA, IBD/UC, onion-skin bile ducts, beading).
Gallstones: cholesterol (most common) vs pigment; ascending cholangitis = Charcot triad/Reynolds pentad with choledocholithiasis/obstruction; acute pancreatitis from gallstones, alcohol, hyperTG; pancreatic adenocarcinoma associates with smoking, chronic pancreatitis, and painless jaundice when head lesions obstruct bile duct.
Last updated: August 2026
14.3 Liver, Biliary Tree & Pancreas
Quick Answer: Split bilirubin into unconjugated vs conjugated pathways. Read hepatitis panels as timelines of antigens/antibodies. Alcohol vs metabolic steatohepatitis both can progress to cirrhosis and portal hypertension. Memorize hemochromatosis, Wilson, α1-AT, PBC vs PSC. Stones + obstruction → cholangitis/pancreatitis; pancreatic head cancers present with painless jaundice.
This section is dense with classic Step-style tables. Anchor every lab pattern to a cellular step: uptake, conjugation, excretion, canalicular flow, or duct patency.
Bilirubin Metabolism
Senescent RBC hemoglobin → heme oxygenase → biliverdin → biliverdin reductase → unconjugated bilirubin (insoluble, albumin-bound). Hepatocyte uptake → UGT1A1 conjugation with glucuronic acid → conjugated (direct) bilirubin excreted into bile canaliculi (MRP2 and related transporters). Gut bacteria convert bilirubin to urobilinogens; some reabsorbed (enterohepatic); stercobilin colors stool; urobilin colors urine.
Unconjugated hyperbilirubinemia: hemolysis/hematoma resorption (↑ production), impaired uptake, or decreased conjugation — Gilbert (mild UGT1A1 ↓, fasting/stress unmasks), Crigler–Najjar (severe UGT deficiency; type I near-absent, kernicterus risk). No bilirubinuria (unconjugated not water-soluble).
Conjugated hyperbilirubinemia: hepatocellular disease impairing excretion, Dubin–Johnson (MRP2 defect; black liver), Rotor (storage/uptake related; no black liver), extrahepatic obstruction (stone, stricture, pancreatic head mass), intrahepatic cholestasis. Dark urine (conjugated bilirubinuria), clay-colored stools if complete biliary obstruction (no stercobilin).
- Pattern Mechanism examples Urine bilirubin Stool color notes
- ↑ Unconjugated Hemolysis, Gilbert, Crigler–Najjar Negative Normal unless severe illness
- ↑ Conjugated (hepatic) Viral hepatitis, Dubin–Johnson Positive Variable
- ↑ Conjugated (obstructive) CBD stone, PSC stricture, pancreatic head ca Positive Pale if complete block
- Viral Hepatitis A–E Serologies
HAV: fecal–oral; acute only (no chronic); IgM anti-HAV = acute; IgG = past/vaccination immunity.
HBV: DNA virus; parenteral/sexual/perinatal. Key markers:
- HBsAg: current infection (acute or chronic)
- Anti-HBs: recovery or vaccination immunity
- Anti-HBc IgM: acute/window; total anti-HBc: exposed (not from vaccine alone)
- HBeAg / HBV DNA: high replication and infectivity; anti-HBe often lower replication
- Window period: HBsAg gone, anti-HBs not yet up → anti-HBc IgM diagnoses acute infection
Chronic HBV: HBsAg >6 months; risk cirrhosis/HCC (integration/inflammation).
HCV: RNA virus; blood-borne; high chronicity; anti-HCV indicates exposure; HCV RNA confirms active infection; major cirrhosis/HCC risk; no classic vaccine.
HDV: defective RNA virus needing HBsAg coat; coinfection or superinfection worsens course.
HEV: fecal–oral; epidemic waterborne; usually acute; high mortality in pregnancy (third trimester classic).
- Virus Route Chronic? Signature test pearl
- HAV Fecal–oral No IgM anti-HAV acute
- HBV Blood/sex/perinatal Yes HBsAg; anti-HBc IgM window
- HCV Blood Yes (common) RNA confirms activity
- HDV With HBV Yes Needs HBsAg
- HEV Fecal–oral Rare (immunocomp.) Severe in pregnancy
- Steatohepatitis, Cirrhosis, Portal Hypertension
Alcoholic liver disease spectrum: steatosis → alcoholic hepatitis → cirrhosis. Alcoholic hepatitis: neutrophil infiltrates, Mallory–Denk bodies, ballooning; AST:ALT ratio often ≥2:1 (mitochondrial AST, ALT synthesis limit). NAFLD/NASH: metabolic syndrome (obesity, insulin resistance, T2DM, dyslipidemia); histology can mirror alcohol (steatosis, ballooning, Mallory bodies, fibrosis) without significant alcohol—clinical history separates.
Cirrhosis is diffuse fibrosis + regenerative nodules destroying architecture. Portal hypertension (↑ resistance in sinusoids + splanchnic vasodilation/hyperdynamic circulation) yields:
- Esophageal/gastric varices , portal gastropathy
- Ascites (underfill + overflow + hypoalbuminemia + Na retention)
- Splenomegaly → sequestration thrombocytopenia
- Portosystemic shunting → hepatic encephalopathy (ammonia and other toxins; asterixis)
- Caput medusae, hemorrhoids (collaterals)
- Hepatorenal physiology conceptually (splanchnic vasodilation → renal vasoconstriction)
Failure of synthetic function: ↓ albumin, ↑ PT/INR; detox failure; estrogen excess signs (palmar erythema, spider angiomas, gynecomastia) in chronic liver disease.
Metabolic and Cholestatic Liver Diseases
Hereditary hemochromatosis: HFE mutations (C282Y classic) → low hepcidin → uncontrolled Fe absorption → parenchymal iron overload (liver, pancreas “bronze diabetes,” heart, joints, pituitary). Prussian blue iron; risk HCC; treat with phlebotomy conceptually.
Wilson disease: ATP7B copper ATPase defect → failed copper incorporation into ceruloplasmin and biliary copper excretion → hepatic injury, neuropsychiatric disease, Kayser–Fleischer rings, low ceruloplasmin, high hepatic copper, low alkaline phosphatase relative in acute liver failure patterns sometimes tested.
α1-Antitrypsin deficiency: PiZZ misfolded AAT retained in ER → PAS-positive diastase-resistant globules in hepatocytes + lung emphysema (loss of antiprotease in serum). Liver disease from retention; lung from lack of circulating AAT.
Primary biliary cholangitis (PBC): middle-aged women; autoimmune destruction of intrahepatic interlobular bile ducts; anti-mitochondrial antibodies (AMA) ; fatigue, pruritus, cholestatic enzymes (↑ALP/GGT); florid duct lesions; can progress to cirrhosis; associated with other autoimmunity (Sicca, thyroid).
Primary sclerosing cholangitis (PSC): fibro-obliterative inflammation of intra- and extrahepatic bile ducts; “onion-skin” fibrosis; multifocal strictures/beading on cholangiography; strong UC/IBD link; p-ANCA often positive; ↑ risk cholangiocarcinoma; men more than PBC demographic.
- Feature PBC PSC
- Demographic Middle-aged women Men, IBD (UC)
- Antibody AMA p-ANCA (nonspecific)
- Ducts Intrahepatic small ducts Intra- and extrahepatic
- Imaging Often normal large ducts Beading/strictures
- Cancer risk HCC if cirrhotic Cholangiocarcinoma
- Gallstones, Cholangitis, Pancreatitis, Pancreatic Cancer
Cholesterol stones (most common in US): supersaturated cholesterol bile, female, forty, fertile, fat, rapid weight loss, Native American ancestry pearls. Black pigment stones: unconjugated bilirubin (hemolysis, cirrhosis). Brown pigment stones: infection/parasites, bile duct stasis, Asian ascending cholangitis associations.
Complications of cholelithiasis: biliary colic, acute cholecystitis (cystic duct obstruction, often secondary infection), choledocholithiasis, gallstone pancreatitis , gallstone ileus (fistula, Rigler triad conceptually).
Ascending cholangitis: biliary obstruction + infection (E. coli, Klebsiella, Enterococcus); Charcot triad (RUQ pain, jaundice, fever); Reynolds pentad adds hypotension and mental status change (severe). Life-threatening; needs biliary decompression conceptually.
Acute pancreatitis: premature zymogen activation and autodigestion; gallstones (ampullary obstruction) and alcohol lead causes; also hypertriglyceridemia (often >1000 mg/dL), hypercalcemia, drugs, trauma (seatbelt/ERCP), mumps, scorpion in lore. Clinical: epigastric pain to back, ↑ amylase/lipase; complications necrosis, infection, pseudocyst, ARDS, hypocalcemia (soap formation). Chronic pancreatitis: recurrent injury, fibrosis, calcifications, malabsorption (fat), diabetes (islet loss); alcohol dominant in many regions; CF in children.
Pancreatic adenocarcinoma: ductal origin; head > body/tail; smoking strongest modifiable risk; chronic pancreatitis, diabetes, age. Head tumors → painless obstructive jaundice , pale stools, dark urine, Courvoisier gallbladder (painless palpable GB), migratory thrombophlebitis (Trousseau). Body/tail present later with pain/weight loss. Tumor markers (CA19-9) clinical adjunct, not primary CBSE mechanism.
Integrate: conjugated bilirubin + dilated ducts → obstruction until proven otherwise; unconjugated + anemia → hemolysis; AST:ALT 2:1 + history → alcohol; AMA woman → PBC; IBD + beading → PSC; epigastric pain through to back after heavy meal/alcohol → pancreatitis until labs say otherwise.